No. S 614
Misuse of Drugs Act
(CHAPTER 185)
Misuse of Drugs Act
(Amendment of Fifth Schedule) Order 2015
In exercise of the powers conferred by section 58A of the Misuse of Drugs Act, the Minister for Home Affairs makes the following Order:
Citation and commencement
1.  This Order may be cited as the Misuse of Drugs Act (Amendment of Fifth Schedule) Order 2015 and comes into operation on 1 November 2015.
Amendment of Fifth Schedule
2.  The Fifth Schedule to the Misuse of Drugs Act is amended —
(a)by deleting items (1) to (18) of paragraph 1 and substituting the following items:
“(1)2-Amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one (also known as bk-2C-B) and its bromo and dimethoxy positional isomers in the phenyl ring
(2)N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as MAB-CHMINACA)
(3)N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-ADB-PINACA) and its fluoro positional isomers in the pentyl group
(4)N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (also known as ADB-PINACA)
(5)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide (also known as 5-Chloro-AB-PINACA) and its chloro positional isomers in the pentyl group
(6)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as AB-CHMINACA)
(7)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-AB-PINACA) and its fluoro positional isomers in the pentyl group
(8)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (also known as AB-PINACA)
(9)N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as PX-2) and its fluoro positional isomers in the pentyl group
(10)N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (also known as PX-1) and its fluoro positional isomers in the pentyl group
(11)1-(1-Benzofuran-5-yl)-N-ethylpropan-2-amine (also known as 5-EAPB) and its 4-yl, 6-yl and 7-yl isomers
(12)2-(2,5-Dimethoxyphenyl)ethanamine (also known as 2C-H) and its dimethoxy positional isomers in the phenyl ring
(13)Ethylphenidate
(14)[1-(5-Fluoropent-1-yl)-1H-benzimidazol-2-yl](naphthalen-1-yl)methanone (also known as FUBIMINA) and its fluoro positional isomers in the pentyl group
(15)[1-(5-Fluoropent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (also known as THJ-2201) and its fluoro positional isomers in the pentyl group
(16)1-(1H-Indol-5-yl)propan-2-amine (also known as 5-IT) and its 4-yl, 6-yl and 7-yl isomers
(17)2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (also known as 2C-I) and its dimethoxy and iodo positional isomers in the phenyl ring
(18)Methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (also known as MDMB-CHMINACA)
(19)Methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as MA-CHMINACA)
(20)Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as 5-Fluoro-AMB) and its fluoro positional isomers in the pentyl group”; and
(b)by inserting, immediately after paragraph 1, the following paragraph:
“2.Any compound (other than serotonin or a Class A drug) structurally derived from 2-(1H-indol-3-yl)ethanamine (also known as tryptamine) by modification in any of the following ways:
(a)substitution at the nitrogen atom of the side chain to any extent with alkyl or alkenyl substituents, or by inclusion of only the nitrogen atom of the side chain in a cyclic structure;
(b)substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;
(c)substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, hydroxy, thioalkyl, alkylenedioxy or halide substituents;
(d)substitution at the 2-position of the tryptamine ring system with an alkyl substituent,
 including any acyl derivative, ether, salt or stereoisomeric form of any such compound, any preparation or product containing any such compound, and the following examples of such a compound:
(1)4-Acetoxy-N,N-diisopropyltryptamine (also known as 4-Acetoxy-DiPT or 4-AcO-DiPT);
(2)4-Acetoxy-N,N-dimethyltryptamine (also known as 4-Acetoxy-DMT or 4-AcO-DMT);
(3)5-Benzyloxytryptamine;
(4)5-Bromo-N,N-dimethyltryptamine (also known as 5-Bromo-DMT);
(5)5-Bromotryptamine;
(6)5-Chloro-α-methyltryptamine (also known as 5-Chloro-AMT);
(7)5-Chlorotryptamine;
(8)N,N-Diallyltryptamine;
(9)N,N-Diisopropyltryptamine;
(10)N,N-Dipropyltryptamine;
(11)5-Fluoro-N,N-dimethyltryptamine (also known as 5-Fluoro-DMT);
(12)5-Fluoro-α-methyltryptamine (also known as 5-Fluoro-AMT);
(13)5-Fluorotryptamine;
(14)4-Hydroxy-N,N-diethyltryptamine (also known as 4-Hydroxy-DET or 4-HO-DET);
(15)4-Hydroxy-N,N-diisopropyltryptamine (also known as 4-Hydroxy-DiPT or 4-HO-DiPT);
(16)4-Hydroxy-N-methyl-N-ethyltryptamine (also known as 4-Hydroxy-MET or 4-HO-MET);
(17)4-Hydroxy-N-methyl-N-isopropyltryptamine (also known as 4-Hydroxy-MiPT or 4-HO-MiPT);
(18)4-Hydroxy-α-methyltryptamine (also known as 4-Hydroxy-AMT or 4-HO-AMT);
(19)5-Hydroxy-N-methyltryptamine (also known as 5-Hydroxy-NMT or 5-HO-NMT);
(20)5-Methoxy-N,N-diallyltryptamine (also known as 5-Methoxy-DALT or 5-MeO-DALT);
(21)5-Methoxy-N,N-diethyltryptamine (also known as 5-Methoxy-DET or 5-MeO-DET);
(22)5-Methoxy-N,N-dipropyltryptamine (also known as 5-Methoxy-DPT or 5-MeO-DPT);
(23)5-Methoxy-N-ethyl-N-isopropyltryptamine (also known as 5-Methoxy-EiPT or 5-MeO-EiPT);
(24)5-Methoxy-N-ethyl-N-propyltryptamine (also known as 5-Methoxy-EPT or 5-MeO-EPT);
(25)5-Methoxy-α-ethyltryptamine (also known as 5-Methoxy-AET or 5-MeO-AET);
(26)5-Methoxy-N-methyl-N-isopropyltryptamine (also known as 5-Methoxy-MiPT or 5-MeO-MiPT);
(27)5-Methoxy-α-methyltryptamine (also known as 5-Methoxy-AMT or 5-MeO-AMT);
(28)5-Methoxy-N-methyltryptamine (also known as 5-Methoxy-NMT or 5-MeO-NMT);
(29)4-Methyl-α-ethyltryptamine (also known as 4-Methyl-AET);
(30)5-Methyltryptamine;
(31)α-Methyltryptamine;
(32)N-Methyltryptamine.”.
Made on 28 October 2015.
LEO YIP
Permanent Secretary,
Ministry of Home Affairs,
Singapore.
[MHA 112/2/0049; AG/LEGIS/SL/185/2015/1 Vol. 1]